A Randomized, Placebo Controlled Clinical Study to Assess the Effect of a Blend of Digestive Enzymes and Extracts on Bloating in Adults.
1 other identifier
interventional
50
1 country
1
Brief Summary
Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study, where participants will take the Daily Supplement, and record Daily Symptoms, two clinical visits where Hydrogen and Methane Breath Test (HMBT) will be conducted, Abdominal Circumference Measurement will be taken, and two Self Reported Validated Questionnaires: Visual Analogue Scale (VAS) and the Quality of Life Questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jul 2025
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedStudy Start
First participant enrolled
July 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedJune 24, 2025
June 1, 2025
1 month
June 13, 2025
June 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To determine the impact of BTB on hydrogen and methane production in healthy adults
Participants will take the Hydrogen and Methane Breath Test (HMBT) at baseline and after the study at Week4.
From time of enrollement to end of study at Week4
Secondary Outcomes (2)
To estimate the changes in abdominal circumference as an indicator of distention
From time of enrollement to end of study at Week4
To assess the changes in validated subjective questionnaire (VAS) for bloating, abdominal pain, distension, and flatulence.
From time of enrollement to end of study at Week4
Study Arms (2)
Placebo
PLACEBO COMPARATOROral dietary supplement. Instructions: Take 1 capsule with water as needed, up to 3 capsules per day. Do not take more than 3.
Dietary Supplement with actives
ACTIVE COMPARATOROral dietary supplement. Instructions: Take 1 capsule with water as needed, up to 3 capsules per day. Do not take more than 3.
Interventions
Dietary Supplement containing blend of Digestive Enzymes, Dandelion, Ginger \& Fennel Extracts
Eligibility Criteria
You may qualify if:
- Healthy Adults aged 18-65 years
- Reported bloating and/or distention occurring at least once per week for the past 6 months, with symptoms actively present during the past 3 months
- Willingness to avoid probiotics, antibiotics, or other supplements during the study period (unless approved by investigators)
- Ability to provide informed consent and comply with all protocol requirements
You may not qualify if:
- Diagnosed gastrointestinal diseases (e.g., inflammatory bowel disease, celiac disease, GI malignancies)
- Use of antibiotics, laxatives, or probiotics within the past 4 weeks
- Uncontrolled diabetes mellitus
- Presence of mood disorders or psychiatric illness that may affect symptom perception or study compliance
- Immunodeficiency, autoimmune conditions, or chronic inflammatory conditions
- Excessive alcohol intake (\>14 drinks/week for men, \>7 drinks/week for women)
- Use of medications known to affect gut motility or gas production (e.g., opioids, anticholinergics)
- Pregnant or breastfeeding women
- Use of systemic corticosteroids or immunosuppressant drugs.
- History of reaction to the category of product tested
- Other diseases or medications that might directly interfere in the study or put the subject's health under risk.
- Employee of CRO or product manufacturer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Olly, PBClead
Study Sites (1)
MusB Research
New Port Richey, Florida, 34653, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 24, 2025
Study Start
July 14, 2025
Primary Completion
August 25, 2025
Study Completion
September 15, 2025
Last Updated
June 24, 2025
Record last verified: 2025-06